A government official said on Friday that he expects two leading drug manufacturers to produce 1 million doses of antibody treatments to be administered to the public at no cost.
Department of Health and Human Services official Paul Mango told reporters that the government’s Operation Warp Speed program already has produced “a couple of hundred thousand doses” of the treatments so far.
Mango said the department expects 1 million doses of the antibody treatments to be produced by Regeneron Pharmaceuticals and Eli Lilly & Company by the end of 2020. Mango reiterated President Trump, who said earlier this week that the drugs would be given to patients who need them for free.
Both Regeneron and Eli Lilly have insisted that their treatments, which differ in their administration, have been shown to be safe during clinical trials. Regeneron’s drug relies on a mix of two antibodies, while Eli Lilly’s contains a single antibody dosage.
Trump has touted the efficacy of Regeneron’s drug, saying after his recovery that the drug made him feel better than he did “20 years ago.”
Both companies have submitted emergency use authorization to the Food and Drug Administration, although it remains unclear how long it could take for the FDA to fast-track the treatments. Trump was granted a compassionate use authorization and given access to the drug during his stay at Walter Reed National Military Medical Center.
Tags: News, Donald Trump, Coronavirus, Health, Health, Public Health, Health Care
Original Author: Spencer Neale
Original Location: Department of Health expects 1 million doses of COVID-19 antibody treatments by end of 2020